Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.
about
The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System TumorsCopper and angiogenesis: unravelling a relationship key to cancer progression.Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.Bevacizumab for the treatment of recurrent glioblastoma.CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells.Angiogenesis-independent tumor growth mediated by stem-like cancer cells.Cancer cell-selective killing polymer/copper combination.Importance of Serum Copper and Vascular Endothelial Growth Factor (VEGF-A) Levels in Postmenopausal BleedingHyaluronan regulates ceruloplasmin production by gliomas and their treatment-resistant multipotent progenitorsCombinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma.D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosisCopper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSVTurning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistryRole of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression.Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiformeEmerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas.Penicillamine revisited: historic overview and review of the clinical uses and cutaneous adverse effects.Targeting copper in cancer therapy: 'Copper That Cancer'.Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials.New Directions in Anti-Angiogenic Therapy for Glioblastoma.A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatmentLow-glucose conditions of tumor microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells.Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo.Copper isotope effect in serum of cancer patients. A pilot study.Combination Therapy with Low Copper Diet, Penicillamine and Gamma Knife Radiosurgery Reduces VEGF and IL-8 In Patients with Recurrent GlioblastomaD-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H2O2-mediated oxidative stress.Peptides derived from histidine and methionine-rich regions of copper transporter 1 exhibit anti-angiogenic property by chelating extracellular Cu.Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis.
P2860
Q28087476-400996A9-5E9B-4D5B-8165-858047FA9702Q34503515-4646AD24-5A68-4CC8-B195-72F626D6BB59Q34618239-D07D82EB-3060-42B3-81B0-D57A9EA02999Q34982777-75540B1F-4906-40BA-9104-FAE6FF6C36A6Q34988260-B3F3154E-445B-4BFC-81C6-FAFB71D89E94Q35103863-F3BC2F8D-6CC5-4AB4-9392-2C6466B75446Q36372931-18CF2D28-3C62-428F-95A0-83D8294B8F55Q36732182-17598D3B-0901-40B1-A3EC-DF5112243777Q36806631-7F9271A6-B188-40CB-8783-675A6EAC286BQ36849213-2DF538D1-43DD-4C46-BC93-507EDBF28823Q37155599-FEFB52BB-C832-479B-842E-95E9EEE678D0Q37189245-DF51B3C0-328D-419D-979A-C719D8DB6D45Q37199661-3665E642-481F-4AE3-9AD5-A6C408ACF27BQ37206068-8F77680F-E94B-4C17-B47D-F338EA9BC9ABQ37218231-1F07BFCB-25E7-4DBF-9495-A21050B5E3B3Q37325097-17098667-4E54-4B18-92C4-31AAFE7A3C1CQ37659384-510FD9D8-773C-48FF-8884-7FE5A7B0885EQ37766531-4C2452E2-0597-4D0B-8B49-91FC3CF3A15BQ38100669-AA46F760-3525-4620-A683-A91C3CF29813Q38575035-7F861BAA-7CD7-4422-A666-CEBA14BC2550Q38720644-B325D770-C8DA-4CD4-AA45-38A7119F6AC1Q39022941-2153F8AC-1DE1-488F-B7DF-5C2E3ACC243AQ39121383-AC404A47-6016-467C-B869-E26A70BFD0A7Q39125256-932AA746-22F6-47CE-8411-B99707A1F4C4Q39429294-9F08468D-F538-43EF-9679-6D315E11FE0DQ41658752-050E1300-598A-4C4B-B88B-A898AC580677Q42672703-453BF48E-EF94-4596-8B37-50EA8AB2AB1CQ46387857-C7B4710C-9600-4D8C-A09C-2FED5866E125Q47405880-461FBE52-9B6D-4B3F-A5DD-3171C364B881Q55091136-4E946C7D-06F2-4318-A1BC-EDBDC283DC98
P2860
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Phase 2 trial of copper deplet ...... nesis therapy of glioblastoma.
@ast
Phase 2 trial of copper deplet ...... nesis therapy of glioblastoma.
@en
type
label
Phase 2 trial of copper deplet ...... nesis therapy of glioblastoma.
@ast
Phase 2 trial of copper deplet ...... nesis therapy of glioblastoma.
@en
prefLabel
Phase 2 trial of copper deplet ...... nesis therapy of glioblastoma.
@ast
Phase 2 trial of copper deplet ...... nesis therapy of glioblastoma.
@en
P2093
P2860
P1433
P1476
Phase 2 trial of copper deplet ...... nesis therapy of glioblastoma.
@en
P2093
Jane B Alavi
Joy D Fisher
Kathryn A Carson
New Approaches to Brain Tumor Therapy CNS Consortium
Pamela New
Steven Brem
Stuart A Grossman
Surasak Phuphanich
Tom Mikkelsen
P2860
P304
P356
10.1215/S1152851704000869
P577
2005-07-01T00:00:00Z